Prognostic Factor | Univariate (n = 142) | Multivariate (n = 129c) | |||
---|---|---|---|---|---|
 | HR (95 % CI) | P-value | HR (95 % CI) | P-value | |
Menacalc | |||||
 | High vs. Low | 2.14 (1.05, 4.58) | 0.0445 | 3.80 (1.58, 9.97) | 0.0052 |
Her2a | |||||
 | Positive vs. Negative | 1.59 (0.43, 4.31) | 0.4234 | 1.35 (0.34, 4.02) | 0.6376 |
Tumor Size | |||||
 | ≥2 cm vs. <2 cm | 2.05 (1.01, 4.22) | 0.0508 | 1.41 (0.62, 3.23) | 0.4178 |
ERa | |||||
 | Negative vs. Positive | 1.62 (0.68, 3.51) | 0.2504 | 0.99 (0.36, 2.51) | 0.9863 |
PR* | |||||
 | Positive vs. Negative | 2.84 (1.27, 7.05) | 0.0173 | NAb | NAb |
Histological grade | |||||
 | Grade 2-3 vs. Grade 1 | 2.61 (1.09, 7.43) | 0.0505 | 1.85 (0.67, 5.84) | 0.2719 |
 | ND vs. Grade 1 | 1.46 (0.39, 5.23) | 0.5667 | 1.34 (0.33, 5.03) | 0.6763 |
Lymphatic invasion | |||||
 | Present vs. Absent | 2.11 (0.81, 4.75) | 0.0993 | 1.63 (0.54, 4.16) | 0.3537 |
Age, years | |||||
 | ≥50 vs. <50 | 2.41 (1.03, 6.77) | 0.0666 | 3.03 (1.17, 9.11) | 0.0348 |